Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 4/18/2025VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...
  • 4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...
  • 4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
  • 4/17/2025Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger
  • 4/17/2025Latticon Pioneers China's First Pipeline-Backed Financing Deal
  • 4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
  • 4/17/2025Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...
  • 4/17/2025DualityBio Raises $211M in Hong Kong IPO
  • 4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
  • 4/15/2025U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...
  • 4/15/2025Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...
  • 4/14/2025Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...
  • 4/14/2025iRegene Advances Chemically-Induced iPSC Platform, Pioneers Cell Thera...
  • 4/14/2025Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
  • 4/11/2025YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...
  • 4/10/2025Sumitomo Pharma Transfers Asian/Chinese Operations Amid Industry-Wide ...
  • 4/10/2025Trump's Planned Tariffs on Imported Pharmaceuticals Target China
  • 4/9/2025BioDuro Expands China Operations with New R&D and Manufacturing Campus...
  • 4/9/2025U.S. Urged to Boost Biotech Investment to Counter China's Strategic Ad...
  • 4/8/2025China Approves Hansoh's Ibrexafungerp for Vaginal Yeast Infections
  • 4/8/2025Duality Bio Upsizes IPO Amid Global Market Challenges
  • 4/8/2025Asia-Pacific Vaccine Market Set for Steady Growth Through 2035 Despite...
  • 4/8/2025Tariffs Spark Market Jitters, But China's Innovative Drug Sector Remai...
  • 4/8/2025Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...
  • 4/8/2025TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China
  • 4/8/2025Rigerna Thera Advances siRNA Drug Development with Pre-A Financing​
  • 4/7/2025Boehringer Ingelheim Highlights Long-Term Commitment to China, Focuses...
  • 4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations
  • 4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
  • 4/5/2025Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy
  • Page:1/21 Total number of articles:607: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group